Table 1 Patient characteristics

Male

18 (20)

Age (years)

38.5 ± 11.1

BMI (kg/m²)

45.46 ± 6.26

Weight (kg)

121.34 ± 20.32

Waist Circumference (cm)

133.04 ± 13.6

Height (m)

1.62 ± 8.87

Diabetes Type 2

25 (27.8)

Hypertension

23 (25.6)

Metabolic syndrome

46 (51.1)

Liver stiffness measurement (kPa)

6.1 ± 1.25

Body fat per cent, %

46.72 ± 5.47

Fat mass, kg

56.62 ± 11.58

Fat-free mass, kg

64.51 ± 12.35

Hs-CRP (mg/L)

5.05 (2.4—13.6)

Fibrosis stage

0 = No fibrosis

38 (42.2)

 1 = Zone 3 perivenular or pericellular fibrosis

40 (44.4)

 2 = Stage 1 plus portal fibrosis

 3 = Bridging fibrosis, focal or extensive

8 (8.8)

4 (4.4)

 4 = Residual pericellular fibrosis

–

NASH

 No NASH (0–2)

39 (43.3)

 NASH (3–8)

51 (56.7)

Steatosis

 S0 =  < 5%

39 (43.3)

 S1 = 5–33%

31 (34.4)

 S2 = 34–66%

12 (13.3)

 S3 =  > 66%

8 (8.9)